10/2/26 21:29 | 9/30/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.dm | 363 | 14.50 | 0 | 25 | 46 | 80 | D | | | | | | | | | | | | | | |
10/2/26 21:29 | 9/30/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.dm | -2,262 | 90.47 | 0 | -25 | -24 | 80 | D | | | | | | | | | | | | | | |
9/3/26 21:33 | 9/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 109 | 14.50 | 0 | 8 | 10 | 80 | D | | | | | | | | | | | | | | |
9/3/26 21:33 | 9/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.dm | -2,284 | 88.75 | 0 | -26 | -24 | 80 | D | | | | | | | | | | | | | | |
8/5/26 21:32 | 8/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 109 | 14.50 | 0 | 8 | 8 | 98 | D | | | | | | | | | | | | | | |
8/5/26 21:32 | 8/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -717 | 95.57 | 0 | -8 | -7 | 98 | D | | | | | | | | | | | | | | |
7/2/26 21:33 | 7/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 109 | 14.50 | 0 | 8 | 8 | 98 | D | | | | | | | | | | | | | | |
7/2/26 21:33 | 7/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -658 | 87.74 | 0 | -8 | -7 | 98 | D | | | | | | | | | | | | | | |
6/26/26 21:31 | 6/25/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 218 | 14.50 | 0 | 15 | 18 | 98 | D | | | | | | | | | | | | | | |
6/26/26 21:31 | 6/25/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -1,307 | 87.13 | 0 | -15 | -13 | 98 | D | | | | | | | | | | | | | | |
6/3/26 21:30 | 6/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 109 | 14.50 | 0 | 8 | 8 | 98 | D | | | | | | | | | | | | | | |
6/3/26 21:30 | 6/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -533 | 71.06 | 0 | -8 | -7 | 98 | D | | | | | | | | | | | | | | |
5/1/26 21:35 | 5/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 181 | 14.50 | 0 | 13 | 15 | 98 | D | | | | | | | | | | | | | | |
5/1/26 21:35 | 5/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -892 | 71.37 | 0 | -13 | -11 | 98 | D | | | | | | | | | | | | | | |
4/3/26 21:29 | 4/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 109 | 14.50 | 0 | 8 | 8 | 98 | D | | | | | | | | | | | | | | |
4/3/26 21:29 | 4/1/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -370 | 49.34 | 0 | -8 | -7 | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:32 | 3/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | M.d | 36 | 14.50 | 0 | 3 | 3 | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:32 | 3/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -102 | 40.65 | 0 | -3 | -2 | 98 | D | | | | | | | | | | | | | | |
9/3/25 18:53 | 9/2/25 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -300 | 16.26 | 0 | -18 | -16 | 98 | D | | | | | | | | | | | | | | |
9/5/24 16:04 | 9/3/24 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -522 | 28.17 | 0 | -19 | -14 | 116 | D | | | | | | | | | | | | | | |